14 to 18-year-old adolescents are at an increased risk to initiate smoking when they start to work, according to researchers from the Johns Hopkins Bloomberg School of Public Health. Investigators found that adolescents who worked more than 10 hours per week also started smoking at an earlier age than their peers.
Healthy living concerns such as obesity and eating healthy foods top the list of health issues for B.C. children aged 10 to 16 years old, according to a report presented to Health Minister George Abbott today by Child Health BC at the conclusion of the one-year public input into the Conversation on Health.
Lymph nodes can be crucial for spreading low doses of infective prion agents -the pathogens responsible for conditions such as scrapie and Creutzfeldt-Jakob disease – into the nervous system, according to new research published in the online open access journal BMC Veterinary Research.
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
The U.S. Food and Drug Administration announced the approval of Lamisil Oral Granules for the treatment of tinea capitis, a fungal infection of the scalp, in children ages 4 years and older.
Novartis and the Massachusetts Institute of Technology have launched a long-term research collaboration aimed at transforming the way pharmaceuticals are produced. The 10-year partnership, known as the Novartis-MIT Center for Continuous Manufacturing, will work to develop new technologies that could replace the conventional batch-based system in the pharmaceuticals industry – which often includes many interruptions and work at separate sites – with continuous manufacturing processes from start to finish.
Three specialists in gastrointestinal and brain cancers recently joined the James P. Wilmot Cancer Center at the University of Rochester Medical Center to meet the growing need in the Rochester and Upstate New York region.
The National Autism Association (NAA) says that a CDC study of only 1047 participants, low compliance rate, and very little data variation–limitations that would ordinarily bar publication in any reputable journal–appears to misinform the public.
MIT scientists have proved that microRNAs, tiny molecules that fine-tune protein production and play a powerful role in biological processes, can prompt otherwise sedentary cancer cells to move and invade other tissues.
Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient’s quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of The Lancet.